Gainers

• Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 237.6% to $0.65 during Thursday's regular session.
• ADMA Biologics (NASDAQ:ADMA) stock increased by 25.62% to $13.16. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3 earnings report came out yesterday.
• Xeris Biopharma Holdings (NASDAQ:XERS) stock increased by 22.17% to $12.78. The company's market cap stands at $1.9 billion. As per the news, the Q3 earnings report came out today.
• CareCloud (NASDAQ:CCLD) stock rose 19.57% to $2.15. The company's market cap stands at $76.4 million. As per the news, the Q3 earnings report came out today.
• Precision BioSciences (NASDAQ:DTIL) shares rose 18.1% to $9.59. The market value of their outstanding shares is at $224.1 million. The company's, Q3 earnings came out 2 days ago.
• Ardent Health (NYSE:ARDT) shares increased by 17.51% to $15.27. The market value of their outstanding shares is at $1.8 billion. As per the news, the Q3 earnings report came out yesterday.

Losers

• SANUWAVE Health (NASDAQ:SNWV) stock fell 63.2% to $2.11 during Thursday's regular session. The company's market cap stands at $49.2 million.
• Veracyte (NASDAQ:VCYT) shares fell 54.48% to $23.91. The market value of their outstanding shares is at $4.1 billion. As per the press release, Q3 earnings came out yesterday.
• Annovis Bio (NYSE:ANVS) shares fell 42.15% to $0.7. The market value of their outstanding shares is at $51.6 million.
• Akebia Therapeutics (NASDAQ:AKBA) stock fell 35.11% to $0.45. The market value of their outstanding shares is at $192.5 million. The company's, Q3 earnings came out today.
• Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock fell 35.05% to $0.15.
• Adagio Medical Holdings (NASDAQ:ADGM) shares fell 30.4% to $0.06. The market value of their outstanding shares is at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.